By Aveluro Research Team · Editorial policy
DVM (DVM) is a company in Vietnam's Health Care sector, listed on HNX. The stock last traded at 5,400 VND, little changed on the session, giving a market capitalization of 287.1 billion VND.
On valuation, DVM trades at a price-to-earnings ratio of 10.3 and a price-to-book of 0.4. That is a discount to the Health Care sector average P/E of 22.2. Return on equity of 3.6% points to weak profitability relative to the company's equity base, below the sector average of 10.4%. Trailing earnings per share stand at 592 VND.
Aveluro tracks 1 news item mentioning DVM, where recent coverage skews positive (100% of articles). The most recent catalyst was a stake change event — "DSC Securities Acquires 13.9% Stake in Vietnam Medicinal Materials (DVM)". Aveluro's composite model rates DVM 5.2/10 (Hold), blending news sentiment, price momentum, and fundamentals.
Comparable names in the Health Care sector include AGP, AMV and APC.
What matters now
DSC Securities Acquires 13.9% Stake in Vietnam Medicinal Materials (DVM)
Caveat: Not investment advice. · How Aveluro computed this: Aveluro combines extracted event facts, source credibility, ticker context, and market data. Scores are deterministic research signals, not recommendations.